lactic acid has been researched along with sorafenib in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Cormode, DP; Farokhzad, OC; Fayad, ZA; Gianella, A; Kim, Y; Labarre, MP; Langer, R; Mieszawska, AJ; Mulder, WJ; Ozcan, C; Petrov, A; Priem, B; van Rooy, I | 1 |
| Feng, L; Liu, T; Liu, Y; Wang, L; Yao, Y; Yu, D; Zhang, L; Zhang, N | 1 |
| Akker, Nv; Benzina, A; Gagliardi, M; Koole, LH; Molin, DG; Wang, Y | 1 |
| Arora, J; Boonkaew, B; Callaghan, C; Chava, S; Dash, S; He, J; John, VT; Lee, BR; Liu, J; Maddox, MM; Mandava, SH | 1 |
| Cheng, SP; Chuang, JH; Lin, LL; Shieh, DB; Wang, PW; Wang, SY; Wei, YH | 1 |
| Chang, CC; Chen, Y; Chiang, WH; Gao, DY; Lin, TsT; Liu, JY; Liu, YC; Sung, YC | 1 |
| Chen, Y; Chiang, T; Gao, DY; Lin, TsT; Liu, JY; Liu, YC; Sung, YC; Wan, D; Wang, L | 1 |
| Jeong, KY; Kim, HM; Park, M; Sim, JJ | 1 |
| Gui, S; Guo, J; He, N; Huang, Y; Li, Z; Liang, X; Tang, M; Tao, Y | 1 |
| Gnocchi, D; Kurzyk, A; Lentini, G; Mazzocca, A; Mintrone, A; Sabbà, C | 1 |
| Aliberti, A; Buonaguro, L; Caputo, TM; Carriero, MV; Celetti, G; Cicatiello, P; Cusano, A; Cusano, AM; Micco, A; Minopoli, M; Principe, S; Ragone, C; Ruvo, M; Tagliamonte, M | 1 |
11 other study(ies) available for lactic acid and sorafenib
| Article | Year |
|---|---|
Synthesis of polymer-lipid nanoparticles for image-guided delivery of dual modality therapy.
Topics: Angiogenesis Inhibitors; Animals; Antibiotics, Antineoplastic; Doxorubicin; Drug Delivery Systems; Female; Human Umbilical Vein Endothelial Cells; Humans; Lactic Acid; Mice; Mice, Nude; Nanoparticles; Neoplasms; Niacinamide; Optical Imaging; Phenylurea Compounds; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sorafenib | 2013 |
Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Contrast Media; Drug Carriers; Hep G2 Cells; Histidine; Humans; Hydrogen-Ion Concentration; Lactic Acid; Magnetic Resonance Imaging; Mice; Nanoparticles; Neoplasms; Niacinamide; Particle Size; Phenylurea Compounds; Polyesters; Polyethylene Glycols; Polymers; Radiography; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Transplantation, Heterologous | 2014 |
Preparation and structure of drug-carrying biodegradable microspheres designed for transarterial chemoembolization therapy.
Topics: Absorbable Implants; Animals; Antineoplastic Agents; Cell Line, Tumor; Chemoembolization, Therapeutic; Cisplatin; Drug Delivery Systems; Drug Interactions; Drug Liberation; Human Umbilical Vein Endothelial Cells; Humans; Lactic Acid; Mice, Inbred BALB C; Microscopy, Electron, Scanning; Microspheres; Niacinamide; Phenylurea Compounds; Polyesters; Polymers; Porosity; Radiography; Sorafenib | 2015 |
Comparison of sorafenib-loaded poly (lactic/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinoma.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Dose-Response Relationship, Drug; Drug Carriers; Humans; Hydrophobic and Hydrophilic Interactions; Kidney Neoplasms; Kinetics; Lactic Acid; Liposomes; Nanoparticles; Nanotechnology; Niacinamide; Phenylurea Compounds; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Sorafenib; Technology, Pharmaceutical | 2015 |
2-Deoxy-d-Glucose Can Complement Doxorubicin and Sorafenib to Suppress the Growth of Papillary Thyroid Carcinoma Cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxyglucose; Dose-Response Relationship, Drug; Doxorubicin; Drug Combinations; Drug Synergism; Gene Expression; Glycolysis; Humans; Lactic Acid; Mutation; Niacinamide; Oxygen Consumption; Phenylurea Compounds; Proto-Oncogene Proteins B-raf; Sorafenib; Thyroid Gland | 2015 |
CXCR4-targeted lipid-coated PLGA nanoparticles deliver sorafenib and overcome acquired drug resistance in liver cancer.
Topics: Animals; Carcinoma, Hepatocellular; Cell Death; Cell Line, Tumor; Cell Proliferation; Drug Delivery Systems; Drug Resistance, Neoplasm; Endocytosis; Human Umbilical Vein Endothelial Cells; Humans; Lactic Acid; Lipids; Liver Neoplasms; Male; Mice; Nanoparticles; Neoplasm Metastasis; Niacinamide; Phenotype; Phenylurea Compounds; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Receptors, CXCR4; Sorafenib; Survival Analysis; Tumor Microenvironment | 2015 |
Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis.
Topics: Animals; Carbon Tetrachloride; Drug Carriers; Human Umbilical Vein Endothelial Cells; Lactic Acid; Liver; Liver Cirrhosis; Male; Mice; Nanoparticles; Niacinamide; Phenylurea Compounds; Polyethylene Glycols; Polyglactin 910; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Protein Kinase Inhibitors; Sorafenib | 2016 |
Combination Antitumor Effect of Sorafenib via Calcium-Dependent Deactivation of Focal Adhesion Kinase Targeting Colorectal Cancer Cells.
Topics: Antineoplastic Agents; Calcium; Cell Cycle; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Dose-Response Relationship, Drug; Focal Adhesion Kinase 1; HCT116 Cells; HT29 Cells; Humans; Lactic Acid; Signal Transduction; Sorafenib | 2020 |
Sorafenib-Loaded PLGA-TPGS Nanosystems Enhance Hepatocellular Carcinoma Therapy Through Reversing P-Glycoprotein-Mediated Multidrug Resistance.
Topics: alpha-Tocopherol; Animals; ATP Binding Cassette Transporter, Subfamily B; Carcinoma, Hepatocellular; Drug Resistance, Multiple; Glycolates; Humans; Lactic Acid; Liver Neoplasms; Mice; Mice, Nude; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sorafenib; Vitamin E | 2022 |
Inhibition of LPAR6 overcomes sorafenib resistance by switching glycolysis into oxidative phosphorylation in hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Glycolysis; Humans; Lactic Acid; Liver Neoplasms; Oxidative Phosphorylation; Pyruvic Acid; Receptors, Lysophosphatidic Acid; Sorafenib | 2022 |
Sorafenib-Loaded PLGA Carriers for Enhanced Drug Delivery and Cellular Uptake in Liver Cancer Cells.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Carriers; Humans; Lactic Acid; Liver Neoplasms; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sorafenib | 2023 |